Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder of Endocrine Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06305286
What this trial is testing

Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)

Who this might be right for
Type 1 Diabetes Mellitus
University of Chicago 70
Testing effectiveness (Phase 2)Looking for participantsNCT06445062
What this trial is testing

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Who this might be right for
Colorectal CancerCRCPancreatic Ductal Adenocarcinoma+3 more
Revolution Medicines, Inc. 1,130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06166589
What this trial is testing

Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer

Who this might be right for
Previously AG Chemotherapy Treated Pancreatic Cancer
Shanghai Zhongshan Hospital 19
Early research (Phase 1)UnknownNCT01218880
What this trial is testing

Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Beijing Protgen Biotechnology Development Co., Ltd. 21
Not applicableStudy completedNCT04789980
What this trial is testing

Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Boryung Pharmaceutical Co., Ltd 799
Testing effectiveness (Phase 2)Ended earlyNCT04203641
What this trial is testing

L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Helix BioPharma Corporation 28
Not applicableWithdrawnNCT03707444
What this trial is testing

A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas Cancer

Who this might be right for
Cancer PancreasPain SyndromeCancer Related Pain
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT02332863
What this trial is testing

Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer
University of Colorado, Denver 44
Testing effectiveness (Phase 2)Study completedNCT00550836
What this trial is testing

Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 104
Testing effectiveness (Phase 2)Study completedNCT00397787
What this trial is testing

Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
National Cancer Institute (NCI) 64
Early research (Phase 1)Study completedNCT00480584
What this trial is testing

A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT01560949
What this trial is testing

Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)WithdrawnNCT00386399
What this trial is testing

Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Looking for participantsNCT04172532
What this trial is testing

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8
National Cancer Institute (NCI) 92
Not applicableLooking for participantsNCT07429487
What this trial is testing

Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer

Who this might be right for
Breast CancerColorectal CancerOvarian Adenocarcinoma+2 more
Centre Antoine Lacassagne 98
Not applicableLooking for participantsNCT05376592
What this trial is testing

Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma

Who this might be right for
Pancreas AdenocarcinomaCachexia
Wake Forest University Health Sciences 100
Not applicableStudy completedNCT04031599
What this trial is testing

Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal 30
Not applicableLooking for participantsNCT05851534
What this trial is testing

Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas

Who this might be right for
PrehabilitationPancreas CancerSurgery+1 more
Maastricht University Medical Center 2,575
Testing effectiveness (Phase 2)UnknownNCT06202014
What this trial is testing

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

Who this might be right for
Pancreatic CancerRadiotherapyEnvafolimab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 43
Early research (Phase 1)Study completedNCT02894944
What this trial is testing

Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Seoul National University Hospital 9
Next Page